Sunday, November 27, 2022

FDA authorizes first breathalyzer test to detect COVID-19

The US Food and Drug Administration authorized the first breathalyzer test to detect COVID-19.

on Thursday, FDA announced That it was issuing an emergency use authorization for InspectIR COVID-19 Breathalyzer, which detects coronavirus infection through breath samples. The test can provide results in less than three minutes.

Until now, widely available COVID-19 tests are administered by swabbing the inside of people’s nostrils with a Q-tip and then testing the sample, with results ranging from a few minutes for rapid testing to PCR testing. for anywhere.

In a study of over 2,000 people, the test was found to have 91.2% sensitivity (rate of correct detection of COVID-positive samples) and 99.3% specificity (rate of correct detection of negative samples). clinical Trial started in 2020But the device was also specifically tested on the Omron version, the FDA said.

According to the FDA, health care providers can use the test, which is about the size of carry-on luggage, on patients in doctor’s offices, hospitals and mobile testing sites.

var _fbPartnerID = null; if (_fbPartnerID !== null) { fbq('init', _fbPartnerID + ''); fbq('track', "PageView"); }

(function () { 'use strict'; document.addEventListener('DOMContentLoaded', function () { document.body.addEventListener('click', function(event) { fbq('track', "Click"); }); }); })();

Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.

Latest News

Related Stories